Fast Five Quiz: Hyperglycemia Associated With Type 2 Diabetes

Anne L. Peters, MD


January 26, 2022

The American Diabetes Association 2022 Standards of Care recommends an A1c goal of less than 7% for most nonpregnant adults without significant hypoglycemia. If an ambulatory glucose profile/glucose management indicator is used to assess glycemia, a corresponding goal for many nonpregnant adults is time in range of 70% or greater, with time below range less than 4% and time below 54 mg/dL less than 1%.

More stringent targets (ie, lower A1c levels than the goal of less than 7%) may be appropriate and beneficial for certain patients if it can be achieved safely without significant hypoglycemia or other adverse treatment effects, on the basis of clinical judgement and patient preference. Less stringent goals (eg, less than 8%) may be appropriate and beneficial for patients with limited life expectancy or where the harms of treatment outweigh the benefits.

Individualized criteria should always be used to reassess glycemic targets, including:

  • Risks for hypoglycemia or adverse effects

  • Disease duration

  • Life expectancy

  • Important comorbidities

  • Established vascular complications

  • Patient preferences, resources, and support system

Learn more about the management of type 2 diabetes.

Editor's Recommendations


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.